Provided by Tiger Trade Technology Pte. Ltd.

Tonix Pharmaceuticals

12.55
+0.16001.29%
Post-market: 12.670.1200+0.96%19:43 EDT
Volume:369.58K
Turnover:4.68M
Market Cap:215.25M
PE:-1.00
High:12.82
Open:12.57
Low:12.52
Close:12.39
52wk High:39.45
52wk Low:9.40
Shares:17.15M
Float Shares:14.99M
Volume Ratio:0.98
T/O Rate:2.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.4882
EPS(LYR):-14.5713
ROE:-81.82%
ROA:-46.84%
PB:0.97
PE(LYR):-0.86

Loading ...

Tonix Pharma CMO Gregory Sullivan to Retire Aug. 20

Reuters
·
Jul 22

Tonix Pharmaceuticals Publishes Investor Deck Highlighting Tonmya Fibromyalgia Launch Strategy

Reuters
·
Jul 20

Tonix Pharmaceuticals Investor Deck Spotlights Tonmya Fibromyalgia Launch and Late-stage Pipeline Plans

Reuters
·
Jul 17

Tonix Publishes Journal of Virology Study Showing 2022 Mpox Clade Iib up to 100,000-fold Less Virulent than 2003 Clade Iia

Reuters
·
Jul 15

Tonix Pharmaceuticals Announces Publication in the Peer-Reviewed Journal of Virology Assessing Virulence of the 2022 Outbreak Strain of Mpox in New Animal Models

GlobeNewswire
·
Jul 15

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jul 13

Tonix Rises on Medicare Coverage Expansion for Chronic Pain Treatment

Reuters
·
Jul 13

Tonix Pharmaceuticals Announces Major Managed Medicare Payer Agreement for Tonmya®

THOMSON REUTERS
·
Jul 13

Tonix Pharmaceuticals - Announces Medicare Agreement for Tonmya Adding 9 Mln Lives Effective Jan 1, 2027

THOMSON REUTERS
·
Jul 13

Tonix Pharmaceuticals Posts Investor Deck Spotlighting Tonmya Fibromyalgia Launch Strategy

Reuters
·
Jul 08

Analysts’ Top Healthcare Picks: Tonix Pharma (TNXP), Carlsmed, Inc. (CARL)

TIPRANKS
·
Jul 01

Tonix Pharmaceuticals - Enrolls First Patient in Phase 2 Horizon Study of Tnx-102 Sl for Mdd - SEC Filing

THOMSON REUTERS
·
Jun 29

Tonix Pharmaceuticals - Primary Endpoint is Change in Madrs Total Score at Week 6 - SEC Filing

THOMSON REUTERS
·
Jun 29

Tonix Enrolls First Patient in Phase 2 Trial of Tnx-102 SL for Major Depressive Disorder

Reuters
·
Jun 29

Take-Two, Quince, Tonix, CoreWeave, Affirm Trending With Analysts

TIPRANKS
·
Jun 27

Tonix Pharmaceuticals initiated with a Strong Buy at Raymond James

TIPRANKS
·
Jun 25

Tonix Pharmaceuticals publishes investor deck focused on TONMYA fibromyalgia launch and pipeline programs

Reuters
·
Jun 16

Tonix Pharma director Carolyn E. Taylor acquires 1,415 shares worth $14,928.25

Reuters
·
Jun 15

Tonix Pharma management to join BTIG Infectious Disease Day 1x1 meetings

Reuters
·
Jun 11

Tonix Pharma director Richard Newcomb Stillwell acquires 5,000 shares for $58,250

Reuters
·
Jun 10